Charles River Laboratories International, Inc. News Headlines

CRL 
$60.51
*  
0.04
0.07%
Get CRL Alerts
*Delayed - data as of Sep. 22, 2014  -  Find a broker to begin trading CRL now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    CRL Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Healthways Up on Carondelet Deal - Analyst Blog
1/17/2014 6:13:01 PM - Zacks.com

Acorda Therapeutics, Inc. (ACOR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
1/17/2014 8:00:01 AM - Zacks.com

MannKind Slips on Afrezza Update - Analyst Blog
1/13/2014 2:22:01 PM - Zacks.com

AstraZeneca's Farxiga Gets FDA Nod - Analyst Blog
1/9/2014 6:00:01 PM - Zacks.com

Intrexon (XON) in Focus: Stock Moves 8.4% Higher - Tale of the Tape
1/9/2014 10:46:01 AM - Zacks.com

FDA Action Date for Orexigen's Contrave - Analyst Blog
1/8/2014 6:20:01 PM - Zacks.com

MedAssets Upped to Hold - Analyst Blog
1/6/2014 7:40:01 PM - Zacks.com

Sanofi's Lemtrada Gets CRL - Analyst Blog
12/31/2013 6:49:01 PM - Zacks.com

Actavis' Women Health Biz Update - Analyst Blog
12/30/2013 3:51:01 PM - Zacks.com

MannKind Corporation (MNKD): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
12/30/2013 8:00:01 AM - Zacks.com

Dynavax Submits Response to EMA - Analyst Blog
12/24/2013 1:10:01 PM - Zacks.com

Update on pSivida's Iluvien - Analyst Blog
12/19/2013 5:17:45 PM - Zacks.com

AVEO Falls on Tivozanib News - Analyst Blog
12/16/2013 7:20:01 PM - Zacks.com

Final Guidance from NICE for pSivida's Iluvien - Analyst Blog
12/5/2013 6:00:01 PM - Zacks.com

MedAssets Shares Rise on Deal Extension - Analyst Blog
12/2/2013 6:53:17 PM - Zacks.com

OREX' Positive Contrave Data Boosts Shares - Analyst Blog
11/26/2013 6:06:41 PM - Zacks.com

Regulatory Setback for Forest/Gedeon - Analyst Blog
11/22/2013 12:06:22 PM - Zacks.com

European Approval for Gilead's Vitekta - Analyst Blog
11/19/2013 12:05:54 PM - Zacks.com

Intrexon Corporation (XON) in Focus: Stock Jumps 8.6% - Tale of the Tape
11/18/2013 10:05:58 AM - Zacks.com

Narrower Q3 Loss at Progenics - Analyst Blog
11/14/2013 10:50:01 AM - Zacks.com

Narrower Loss at Orexigen in Q3 - Analyst Blog
11/14/2013 10:06:40 AM - Zacks.com

Dynavax Reports In-Line Loss, Beats Rev - Analyst Blog
11/8/2013 1:00:01 PM - Zacks.com

Salix Misses On Q3 Earnings; To Buy Santarus - Analyst Blog
11/8/2013 12:06:08 PM - Zacks.com

Orexigen, Sanofi Ink Deal - Analyst Blog
11/7/2013 6:05:26 PM - Zacks.com

PAREXEL's Earnings in Line but Shares Tank - Analyst Blog
11/5/2013 3:00:01 PM - Zacks.com